| Identification | Back Directory | [Name]
Cdc7-IN-4 | [CAS]
1402059-21-5 | [Synonyms]
Cdc7-IN-4
Cdc7 IN 4,Cdc7IN4,Cdc-7-IN-4
3-Furancarboxylic acid, 4,5-dihydro-4-oxo-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-2-[[4-(2,2,2-trifluoroethyl)-1-piperazinyl]amino]-, 1-methylethyl ester | [Molecular Formula]
C22H24F3N5O4 | [MDL Number]
MFCD34469646 | [MOL File]
1402059-21-5.mol | [Molecular Weight]
479.45 |
| Hazard Information | Back Directory | [Uses]
Cdc7-IN-4 (compound I-C) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-C. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1]. | [References]
[1] Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|